《睡眠專業人士雜誌》
星期四, 七月 23, 2026
Ognomy Sleep, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech Ventures, University of Buffalo, and strategic partners who have supported the company’s […]
Here’s an uncomfortable exercise. Tomorrow morning, walk through your sleep lab or practice and ask one question: “Has anyone here ever used ChatGPT, Claude, Gemini, or another AI tool for work?” If the answer is no, chances are someone isn’t being completely honest. Artificial intelligence has become part of the […]
Wesper unveiled its multi-tier sleep diagnostic ecosystem at SLEEP 2026, the annual meeting of the Associated Professional Sleep Societies. The ecosystem brings two purpose-built diagnostic pathways, Wesper Lab and Wesper Lite, onto one platform, one patient record, and one interpretation pipeline, so physicians can match the right test to the right […]
Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA’s Nikolay V. Dokholyan, PhD, and colleagues have developed a suite of artificial intelligence-powered tools, called YuelDesign, YuelPocket and YuelBond, that work together to […]
NightWare, Inc. and Exit 156 Capital announced a strategic investment by Exit 156 in NightWare’s ongoing Series C financing. NightWare is the maker of the only FDA-cleared prescription digital therapeutic indicated for nightmare disorder in adults with post-traumatic stress disorder (PTSD). The partnership unites a Minneapolis-based growth-stage digital health company […]
根據近期發表於《Communications Medicine》期刊的研究結果，西奈山醫院的研究人員開發了一種基於機器學習的分析工具，能夠預測數百萬名患有阻塞性睡眠呼吸中止症（一種嚴重的睡眠障礙）患者的心血管疾病風險。該研究團隊表示，這是首項針對[…]提供風險評估的研究。
即使您並非習慣訂立新年決心的那類人，新年的到來自然會讓人反思：去年哪些事情做得不錯、哪些需要改變，以及該拋下什麼。秉持著這種展望未來的精神，《SleepWorld》雜誌進行了首屆讀者科技問卷調查 […]
AI software designed to help diagnose sleep apnea in children has achieved high accuracy in an NHS trial, with the findings independently reviewed by clinical specialists. Glasgow company Seluna tested its autoscoring and sleep staging software on 500 retrospective sleep studies from NHS Greater Glasgow and Clyde’s Royal Hospital for […]
醫療器材創新與睡眠照護領域的先驅——Sunrise Group 今日宣布，一項經同儕審查的新研究已發表於《自然-通訊醫學》（Nature Communications Medicine）。Sunrise 開發了唯一一款具備呼吸努力測量功能的居家睡眠檢測裝置，且該裝置已通過與參考標準「食道壓力」的對照驗證。該研究顯示，Sunrise 專有的標記物 REMOV […]
